X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare IPCA Labs with Piramal Healthcare - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs PIRAMAL ENTERPRISES - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

PIRAMAL ENTERPRISES 
   Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS PIRAMAL ENTERPRISES IPCA LABS/
PIRAMAL ENTERPRISES
 
P/E (TTM) x 30.5 8.5 356.9% View Chart
P/BV x 4.5 1.6 288.4% View Chart
Dividend Yield % 0.1 1.0 10.0%  

Financials

 IPCA LABS   PIRAMAL ENTERPRISES
EQUITY SHARE DATA
    IPCA LABS
Mar-18
PIRAMAL ENTERPRISES
Mar-18
IPCA LABS/
PIRAMAL ENTERPRISES
5-Yr Chart
Click to enlarge
High Rs6953,083 22.6%   
Low Rs4001,902 21.0%   
Sales per share (Unadj.) Rs260.2589.7 44.1%  
Earnings per share (Unadj.) Rs19.0284.0 6.7%  
Cash flow per share (Unadj.) Rs33.1310.5 10.6%  
Dividends per share (Unadj.) Rs1.0025.00 4.0%  
Dividend yield (eoy) %0.21.0 18.2%  
Book value per share (Unadj.) Rs213.01,467.0 14.5%  
Shares outstanding (eoy) m126.20180.27 70.0%   
Bonus/Rights/Conversions -IS-  
Price / Sales ratio x2.14.2 49.8%   
Avg P/E ratio x28.98.8 329.0%  
P/CF ratio (eoy) x16.68.0 206.4%  
Price / Book Value ratio x2.61.7 151.3%  
Dividend payout %5.38.8 59.9%   
Avg Mkt Cap Rs m69,120449,332 15.4%   
No. of employees `00013.36.8 193.7%   
Total wages/salary Rs m7,35919,881 37.0%   
Avg. sales/employee Rs Th2,477.415,535.6 15.9%   
Avg. wages/employee Rs Th555.22,905.4 19.1%   
Avg. net profit/employee Rs Th180.67,482.5 2.4%   
INCOME DATA
Net Sales Rs m32,836106,310 30.9%  
Other income Rs m4182,595 16.1%   
Total revenues Rs m33,254108,906 30.5%   
Gross profit Rs m4,50551,599 8.7%  
Depreciation Rs m1,7774,773 37.2%   
Interest Rs m24029,783 0.8%   
Profit before tax Rs m2,90519,638 14.8%   
Minority Interest Rs m02,801 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m511-28,764 -1.8%   
Profit after tax Rs m2,39451,203 4.7%  
Gross profit margin %13.748.5 28.3%  
Effective tax rate %17.6-146.5 -12.0%   
Net profit margin %7.348.2 15.1%  
BALANCE SHEET DATA
Current assets Rs m19,455118,154 16.5%   
Current liabilities Rs m10,076462,260 2.2%   
Net working cap to sales %28.6-323.7 -8.8%  
Current ratio x1.90.3 755.4%  
Inventory Days Days9827 368.3%  
Debtors Days Days6747 143.9%  
Net fixed assets Rs m20,260113,727 17.8%   
Share capital Rs m252361 70.0%   
"Free" reserves Rs m26,633264,093 10.1%   
Net worth Rs m26,886264,454 10.2%   
Long term debt Rs m2,340242,206 1.0%   
Total assets Rs m41,173726,834 5.7%  
Interest coverage x13.11.7 789.2%   
Debt to equity ratio x0.10.9 9.5%  
Sales to assets ratio x0.80.1 545.2%   
Return on assets %6.411.1 57.4%  
Return on equity %8.919.4 46.0%  
Return on capital %10.810.3 104.4%  
Exports to sales %47.60-   
Imports to sales %14.90-   
Exports (fob) Rs m15,642NA-   
Imports (cif) Rs m4,884NA-   
Fx inflow Rs m15,64215,110 103.5%   
Fx outflow Rs m4,8844,298 113.6%   
Net fx Rs m10,75910,813 99.5%   
CASH FLOW
From Operations Rs m3,411-159,666 -2.1%  
From Investments Rs m-1,354-17,677 7.7%  
From Financial Activity Rs m-1,304186,503 -0.7%  
Net Cashflow Rs m7539,364 8.0%  

Share Holding

Indian Promoters % 45.9 52.9 86.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.4 4.0 285.0%  
FIIs % 25.3 26.6 95.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.4 16.5 105.5%  
Shareholders   36,892 93,274 39.6%  
Pledged promoter(s) holding % 2.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   DISHMAN PHARMA  ELDER PHARMA  ALEMBIC LTD  DR. DATSONS LABS  CADILA HEALTHCARE  

Compare IPCA LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades Higher; Metal Stocks Lead(12:30 pm)

Stock markets in India are presently witnessing buying interest. The BSE Sensex is trading up by 95 points and the NSE Nifty is trading up by 38 points.

Related Views on News

IPCA LABS Announces Quarterly Results (3QFY19); Net Profit Up 51.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, IPCA LABS has posted a net profit of Rs 2 bn (up 51.7% YoY). Sales on the other hand came in at Rs 9 bn (up 10.3% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY19); Net Profit Up 21.8% (Quarterly Result Update)

Jan 30, 2019 | Updated on Jan 30, 2019

For the quarter ended December 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 21.8% YoY). Sales on the other hand came in at Rs 35 bn (up 22.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

IPCA LABS Announces Quarterly Results (2QFY19); Net Profit Up 24.1% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, IPCA LABS has posted a net profit of Rs 1 bn (up 24.1% YoY). Sales on the other hand came in at Rs 10 bn (up 15.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (2QFY19); Net Profit Up 59.3% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 59.3% YoY). Sales on the other hand came in at Rs 31 bn (up 24.0% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY19); Net Profit Down 423.6% (Quarterly Result Update)

Aug 13, 2018 | Updated on Aug 13, 2018

For the quarter ended June 2018, IPCA LABS has posted a net profit of Rs 655 m (down 423.6% YoY). Sales on the other hand came in at Rs 9 bn (up 19.8% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

The Best Trading Strategy in the World(Profit Hunter)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

Election Series: Why 'Liquor' is so Important to the Elections(The 5 Minute Wrapup)

Apr 19, 2019

When elections come around, liquor flows like water and everyone gets drunk with power...what does this mean for liquor stocks? Read one to find out from our very own election trading analyst, Vijay Bhambwani.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Apr 26, 2019 03:37 PM

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

MARKET STATS